A new study shows a possible new abortion drug to replace mifepristone. But will these results increase abortion access—or restrict women's reproductive health options down the line?
Missouri, Kansas and Idaho can press forward with their lawsuit to restrict access to the abortion drug mifepristone, a federal judge ruled Thursday, months after the US Supreme Court had rejected an ...
Robert F. Kennedy Jr. attempted to walk back his past anti-vaccine and pro-abortion rights stances in his Senate confirmation ...
The Biden administration’s Department of Justice sought to have the case dismissed, arguing that Kansas, Idaho and Missouri ... the decision that the FDA and mifepristone manufacturer Danco ...
Missouri and Idaho officials say they have a separate ... the FDA to reinstate its restrictions on the medication, requiring mifepristone to be dispensed only in person and be used within the ...
A Texas judge has allowed Idaho, Kansas, and Missouri to challenge federal rules on the abortion drug mifepristone. The states want stricter regulations, citing conflict with state abortion laws. The ...
Khaya Himmelman spoke to one of the 60,000 voters in North Carolina whose ballots Republican state Supreme Court candidate ...
The three states argue that the FDA's approval of mifepristone for use up to 10 weeks of pregnancy, along with its availability via telemedicine and mail, has contributed to what they view as a public ...
Robert F. Kennedy Jr. suggested, if confirmed to head the Department of Health and Human Services, he is open to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback